Uniplan Investment Counsel’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-334,035
Closed -$4.8M 148
2021
Q1
$4.8M Sell
334,035
-3,789
-1% -$48.8K 0.31% 64
2020
Q4
$3.19M Buy
337,824
+62,789
+23% +$480K 0.22% 85
2020
Q3
$1.72M Buy
275,035
+61,598
+29% +$448K 0.12% 104
2020
Q2
$1.5M Buy
+213,437
New +$1.52M 0.1% 105

Other funds holding SMED

Uniplan Investment Counsel's SMED Position: Q2 2021 in Review

Uniplan Investment Counsel sold out of Sharps Compliance Corp (SMED) in Q2 2021, closing a stake of 334,035 shares — an estimated $4.8M sold.

Uniplan Investment Counsel first reported a position in SMED in Q2 2020 and held it in 4 quarters. The position peaked at $4.8M in Q1 2021. 83 funds tracked by Wall St. Rank hold SMED as of Q2 2021.

  • Uniplan Investment Counsel reported no remaining Sharps Compliance Corp position as of Q2 2021 after selling out during the quarter.
  • Uniplan Investment Counsel sold 334,035 Sharps Compliance Corp shares in Q2 2021, an estimated $4.8M.
  • Uniplan Investment Counsel first reported a position in Sharps Compliance Corp in Q2 2020 and held it in 4 quarters.
  • Uniplan Investment Counsel's Sharps Compliance Corp position peaked at $4.8M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2021.

Based on Uniplan Investment Counsel's 13F filing for Q2 2021, filed 13 Aug 2021.